Dren Bio

Round
drenbio.com Biotech & Healthcare
Total Funding $415M
Latest Round $350M Round
Last Announced Oct 29, 2026
Investors 18 Backers
Decision Makers 6 Available

About Dren Bio

Dren Bio is a privately held, biopharmaceutical company focused on developing therapeutic antibodies for the treatment of cancer, autoimmune and other serious diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Round
Global Headquarters Undisclosed
Tracked Since Oct 29, 2026

Web & Domain Identity

Official Website drenbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $350,000,000 · Round

    Backed by Juvia Group

  2. Capital Raise

    Raised $65,000,000 · Series-B

    Backed by HBM Healthcare Investments

  3. Capital Raise

    Series-A announced

    Backed by SR One

Investors & Backers

18
HBM Healthcare Investments
Lead
Juvia Group
Lead
SR One
Lead
8VC
Alexandria Venture Investments
ArrowMark Partners
Biotechnology Value Fund
Cormorant Asset Management
General Catalyst
HBM Partners
Jacket River
Lightspeed
Mirae Asset Capital Life Science
Mission BioCapital
OrbiMed
Pfizer Venture Investments
Revelation Partners
Taiho Ventures

Funding History

3 Rounds
Round equity · Oct 29, 2026

Round backers: Juvia Group

$350,000,000 finance.yahoo.com
Series-B equity · Jun 14, 2022

Round backers: HBM Healthcare Investments

$65,000,000 zpr.io
Series-A equity · Oct 16, 2020

Round backers: SR One

Undisclosed zpr.io

Founders & Leadership

2

Amit Mehta

COO

Work email & phone locked Unlock →

Nenad Tomasevic

CEO and Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts